Showing results (1-10 of 1,348) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|December 9, 2022
A Single-center, Open-label, Parallel Control Study Comparing the Pharmacokinetics and Safety of a Single Oral Dose of Roflumilast and Its Active Metabolite Roflumilast N-oxide in Healthy Chinese and Caucasian VolunteersMai Han, Xiao-Yan Lin, Gang Cui, et al.
Clinical Pharmacology in Drug Development|November 23, 2022
Pharmacokinetics, Safety, and Tolerability of the siRNA JNJ-73763989 in Healthy Chinese Adult ParticipantsHaiyan Li, Xiaoye Niu, Yu Zhang, et al.
Clinical Pharmacology in Drug Development|July 6, 2022
Pharmacokinetics and Safety Study of HN0037, a Novel Anti-Human Herpes Simplex Virus Inhibitor, in Healthy VolunteersJie Hou, Hong Gao, Yingzhe Fan, et al.
Clinical Pharmacology in Drug Development|July 6, 2022
Pharmacokinetics and Bioequivalence of Fudosteine in Healthy Chinese Volunteers Under Fasting and Fed Conditions: A 4-Way Replicate Crossover StudyMingxue Zhu, Yi Tao, Junliang Pu, et al.
Clinical Pharmacology in Drug Development|October 10, 2020
Pharmacokinetics of Deutetrabenazine and Tetrabenazine: Dose Proportionality and Food EffectFrank Schneider, David Stamler, Margaret Bradbury, et al.
Clinical Pharmacology in Drug Development|March 27, 2020
Thorough QTc Study of a Single Supratherapeutic Dose of Relebactam in Healthy ParticipantsKeith Boundy, Yang Liu, Pratik Bhagunde, et al.
Clinical Pharmacology in Drug Development|August 28, 2020
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy VolunteersM Judith Peterschmitt, Nigel P S Crawford, Sebastiaan J M Gaemers, et al.
Clinical Pharmacology in Drug Development|September 16, 2020
A Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy ParticipantsKatie Zomorodi, Dan Chen, Lawrence Lee, et al.
Clinical Pharmacology in Drug Development|October 6, 2020
A Phase 1 Dose-Escalation Study of Low-Dose Metronomic Treatment With Novel Oral Paclitaxel Formulations in Combination With Ritonavir in Patients With Advanced Solid TumorsVincent A de Weger, Marit A C Vermunt, Frederik E Stuurman, et al.
Clinical Pharmacology in Drug Development|June 20, 2021
An Open-Label, Randomized, 2-Way, Crossover Bioequivalence Study of Cefradine Capsules in Healthy Chinese VolunteersXiuping Lai, Suiwen Ye, Liuhan Chen, et al.
Pageof 135